USAQOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

QHSLab, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.32+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $7.38M
P/E (TTM): –
Dividend yield: –

QHSLab, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Revenue	2.69	2.13	1.41	1.24	1.41	0.12	–	–	–	–	0	0	0	0	0	0
Cost of Revenue	0.88	0.77	0.62	0.62	0.74	0.07	–	–	–	–	–	–	–	–	–	–
Gross Profit	1.81	1.36	0.79	0.62	0.67	0.05	–	–	–	–	–	–	–	–	–	–
Research & Development	0.48	0.29	0.21	0.19	0.09	0.10	0.10	–	–	–	–	–	–	–	–	–
Selling, General & Admin	1.12	0.79	0.75	0.92	1.05	0.23	–	–	–	–	–	–	–	–	–	–
Selling & Marketing	0.68	0.51	0.49	0.53	0.59	0.10	–	–	–	–	–	–	–	–	–	–
General & Administrative	0.44	0.28	0.26	0.39	0.45	0.13	0.05	0.03	0.00	0.01	0.04	0.03	0.06	0.06	0.07	0.05
Operating Expenses	1.68	1.15	1.03	1.18	1.17	0.33	0.15	0.03	–	–	–	–	–	–	–	–
Total Costs & Expenses	–	–	–	–	–	–	–	0.03	0.00	0.02	0.72	0.04	0.07	0.07	0.08	0.06
Operating Income	0.13	0.21	-0.24	-0.56	-0.50	-0.28	-0.15	-0.03	0.00	-0.02	-0.72	–	–	–	–	–
Interest Expense	0.24	0.47	0.23	0.43	0.25	0.03	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Pretax Income	0.46	-0.26	-0.47	-1.00	-0.77	-0.33	–	–	–	–	–	–	–	–	–	–
Income Tax Expense	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	-0.46	-0.26	-0.47	-1.00	-0.77	-0.33	-0.17	-0.04	-0.01	-0.02	-0.72	-0.04	-0.07	-0.07	-0.08	-0.06
Net Income to Common	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.07	-0.08	–
EPS (Basic)(per share)	0.04	-0.03	-0.05	-0.11	-0.10	-0.05	-0.03	0.00	0.00	0.00	-0.23	-0.04	-0.06	–	–	–
EPS (Diluted)(per share)	0.02	-0.03	-0.05	-0.11	-0.10	-0.05	-0.03	0.00	0.00	0.00	-0.23	-0.04	-0.06	–	–	–
Shares Outstanding (Basic, Weighted)(shares)	11	10	9.42	9.00	7.86	6.20	5.41	3.59	3.59	4.19	3.14	1.09	1.09	–	–	–
Shares Outstanding (Diluted, Weighted)(shares)	19	10	9.42	9.00	7.86	6.20	5.41	3.59	3.59	4.19	3.14	1.09	1.09	–	–	–
EBITDA	0.22	0.35	-0.09	-0.43	-0.47	-0.28	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 67.7%
Operating margin: 2.7%
Net margin: -13.0%
Return on equity, FY2025: -89.9%

Financial strength

Current ratio: 1.82
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 84.5%

Valuation

P/E ratio: –
Price to sales: 2.45
Price to book: 4.74
Dividend yield: –